National Health Investors (NYSE:NHI) Hits New 1-Year Low - What's Next?

Key Points

• National Health Investors shares hit a new 52-week low of $66.55, below their 50-day and 200-day moving averages.
• Analysts maintain a consensus “Moderate Buy” rating with an $82.25 price target, despite mixed actions including a “strong sell” downgrade and several reduced targets.
• The healthcare REIT reported $1.19 in quarterly EPS on $121.32 million in revenue and declared a $0.92 quarterly dividend, representing a 5.5% yield, though its payout ratio is elevated at 106.36%.

Shares of National Health Investors, Inc. (NYSE:NHI - Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $66.55 and last traded at $67.2540, with a volume of 405515 shares. The stock had previously closed at $67.41.

Wall Street Analyst Weigh In

NHI has been the topic of several recent analyst reports. National Bank Financial set a $79.00 target price on shares of National Health Investors in a report on Wednesday, September 9th. Zacks Research cut shares of National Health Investors from a "hold" rating to a "strong sell" rating in a research report on Thursday, June 25th. Wells Fargo & Company dropped their target price on National Health Investors from $79.00 to $78.00 and set an "equal weight" rating for the company in a research report on Tuesday, September 1st. Deutsche Bank Aktiengesellschaft cut their price target on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research note on Thursday, June 25th. Finally, Huntington assumed coverage on shares of National Health Investors in a report on Thursday, September 10th. They issued an "outperform" rating and a $79.00 price objective for the company. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $82.25.

National Health Investors Price Performance

The company has a 50 day moving average of $73.50 and a 200 day moving average of $76.44. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of 19.44, a PEG ratio of 3.60 and a beta of 0.52.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.National Health Investors's revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities research analysts anticipate that National Health Investors, Inc. will post 4.76 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.5%. National Health Investors's payout ratio is presently 106.36%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC boosted its position in shares of National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock worth $51,000 after purchasing an additional 160 shares in the last quarter. Assetmark Inc. increased its holdings in shares of National Health Investors by 13.5% in the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust's stock valued at $110,000 after purchasing an additional 161 shares in the last quarter. Inspire Investing LLC increased its holdings in shares of National Health Investors by 3.2% in the 1st quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust's stock valued at $510,000 after purchasing an additional 198 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of National Health Investors by 1.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,214 shares of the real estate investment trust's stock valued at $1,162,000 after purchasing an additional 204 shares during the period. Finally, Wealthspire Retirement LLC lifted its stake in shares of National Health Investors by 0.9% in the first quarter. Wealthspire Retirement LLC now owns 25,318 shares of the real estate investment trust's stock valued at $2,047,000 after purchasing an additional 221 shares during the period. Institutional investors and hedge funds own 62.51% of the company's stock.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.